{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T16:05:57Z","timestamp":1771776357345,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211380"],"award-info":[{"award-number":["tsqn202211380"]}],"id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M741864"],"award-info":[{"award-number":["2023M741864"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Medical and Health Technology Project of Shandong Province","award":["202318001632"],"award-info":[{"award-number":["202318001632"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11030-025-11268-6","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:43:55Z","timestamp":1751287435000},"page":"1385-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["JAK3 identified as a key toxicological target of aristolochic acid in clear cell renal cell carcinoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Jianhang","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"11268_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0278-6915(02)00219-3","volume":"41","author":"J-R Ioset","year":"2003","unstructured":"Ioset J-R, Raoelison GE, Hostettmann K (2003) Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 41:29\u201336. https:\/\/doi.org\/10.1016\/S0278-6915(02)00219-3","journal-title":"Food Chem Toxicol"},{"key":"11268_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95978","volume":"2","author":"S-Y Chang","year":"2017","unstructured":"Chang S-Y, Weber EJ, Sidorenko VS et al (2017) Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. Jci Insight 2:e95978. https:\/\/doi.org\/10.1172\/jci.insight.95978","journal-title":"Jci Insight"},{"key":"11268_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-8546-3-13","volume":"3","author":"S-C Hsieh","year":"2008","unstructured":"Hsieh S-C, Lin I-H, Tseng W-L et al (2008) Prescription profile of potentially aristolochic acid containing chinese herbal products: an analysis of national health insurance data in taiwan between 1997 and 2003. Chin Med 3:13. https:\/\/doi.org\/10.1186\/1749-8546-3-13","journal-title":"Chin Med"},{"key":"11268_CR4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2215\/CJN.11571017","volume":"13","author":"B Yang","year":"2018","unstructured":"Yang B, Xie Y, Guo M et al (2018) Nephrotoxicity and chinese herbal medicine. Clin J Am Soc Nephrol\u202f: Cjasn 13:1605\u20131611. https:\/\/doi.org\/10.2215\/CJN.11571017","journal-title":"Clin J Am Soc Nephrol : Cjasn"},{"key":"11268_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1039\/C3NP70114J","volume":"31","author":"J Michl","year":"2014","unstructured":"Michl J, Ingrouille MJ, Simmonds MSJ, Heinrich M (2014) Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep 31:676\u2013693. https:\/\/doi.org\/10.1039\/C3NP70114J","journal-title":"Nat Prod Rep"},{"key":"11268_CR6","first-page":"135","volume":"34","author":"R Abdullah","year":"2017","unstructured":"Abdullah R, Diaz LN, Wesseling S, Rietjens IMCM (2017) Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Addit Contam Part A 34:135\u2013144","journal-title":"Food Addit Contam Part A"},{"key":"11268_CR7","doi-asserted-by":"publisher","unstructured":"Chinese Anti-Cancer Association (2019) Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version). Chin J Cancer Res 31:29\u201348. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.02","DOI":"10.21147\/j.issn.1000-9604.2019.01.02"},{"key":"11268_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13046-021-01961-3","volume":"40","author":"R Sharma","year":"2021","unstructured":"Sharma R, Kadife E, Myers M et al (2021) Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. J Exp Clin Cancer Res\u202f: Cr 40:186. https:\/\/doi.org\/10.1186\/s13046-021-01961-3","journal-title":"J Exp Clin Cancer Res : Cr"},{"key":"11268_CR9","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S et al (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9","journal-title":"Nat Rev Dis Primers"},{"key":"11268_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fern\u00e1ndez-Pello S, Giles RH, Hofmann F, Hora M, Klatte T (2022) European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82:399\u2013410. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.006","journal-title":"Eur Urol"},{"key":"11268_CR11","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T et al (2025) PubChem 2025 update. Nucleic Acids Res 53:D1516\u2013D1525. https:\/\/doi.org\/10.1093\/nar\/gkae1059","journal-title":"Nucleic Acids Res"},{"key":"11268_CR12","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52:W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"key":"11268_CR13","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52:W422\u2013W431. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"key":"11268_CR14","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2023","unstructured":"Zdrazil B, Felix E, Hunter F et al (2023) The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52:D1180\u2013D1192. https:\/\/doi.org\/10.1093\/nar\/gkad1004","journal-title":"Nucleic Acids Res"},{"key":"11268_CR15","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, Santos A, von Mering C et al (2016) STITCH 5: Augmenting protein\u2013chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44:D380\u2013D384. https:\/\/doi.org\/10.1093\/nar\/gkv1277","journal-title":"Nucleic Acids Res"},{"key":"11268_CR16","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"key":"11268_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Curr Protoc Bioinform"},{"key":"11268_CR18","doi-asserted-by":"publisher","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","volume":"47","author":"JS Amberger","year":"2019","unstructured":"Amberger JS, Bocchini CA, Scott AF, Hamosh A (2019) OMIM.org: leveraging knowledge across phenotype\u2013gene relationships. Nucleic Acids Res 47:D1038\u2013D1043. https:\/\/doi.org\/10.1093\/nar\/gky1151","journal-title":"Nucleic Acids Res"},{"key":"11268_CR19","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang Y, Zhao D et al (2023) TTD: therapeutic target database describing target druggability information. Nucleic Acids Res 52:D1465\u2013D1477. https:\/\/doi.org\/10.1093\/nar\/gkad751","journal-title":"Nucleic Acids Res"},{"key":"11268_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J et al (2019) Cytoscape automation: empowering workflow-based network analysis. Genome Biol 20:185. https:\/\/doi.org\/10.1186\/s13059-019-1758-4","journal-title":"Genome Biol"},{"key":"11268_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS et al (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28:882\u2013883. https:\/\/doi.org\/10.1093\/bioinformatics\/bts034","journal-title":"Bioinformatics"},{"key":"11268_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Ritchie ME, Phipson B et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"11268_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","journal-title":"BMC Bioinf"},{"key":"11268_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B (2024) Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation 5:100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625","journal-title":"Innovation"},{"key":"11268_CR25","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J et al (2022) CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50:W159\u2013W164. https:\/\/doi.org\/10.1093\/nar\/gkac394","journal-title":"Nucleic Acids Res"},{"key":"11268_CR26","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","volume":"34","author":"AS Rose","year":"2018","unstructured":"Rose AS, Bradley AR, Valasatava Y et al (2018) NGL viewer: Web-based molecular graphics for large complexes. Bioinformatics 34:3755\u20133758. https:\/\/doi.org\/10.1093\/bioinformatics\/bty419","journal-title":"Bioinformatics"},{"key":"11268_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Newman AM, Liu CL et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"11268_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ (2017) Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med 376:354\u2013366. https:\/\/doi.org\/10.1056\/NEJMra1601333","journal-title":"N Engl J Med"},{"key":"11268_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","volume":"17","author":"P Makhov","year":"2018","unstructured":"Makhov P, Joshi S, Ghatalia P et al (2018) Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies. Mol Cancer Ther 17:1355\u20131364. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-1299","journal-title":"Mol Cancer Ther"},{"key":"11268_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.eururo.2023.04.003","volume":"84","author":"BH Cotta","year":"2023","unstructured":"Cotta BH, Choueiri TK, Cieslik M et al (2023) Current landscape of genomic biomarkers in clear cell renal cell carcinoma. Eur Urol 84:166\u2013175. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.003","journal-title":"Eur Urol"},{"key":"11268_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/molecules29010081","volume":"29","author":"C Wang","year":"2023","unstructured":"Wang C, Liu Y, Han J et al (2023) Detection and removal of aristolochic acid in natural plants, pharmaceuticals, and environmental and biological samples: a review. Molecules 29:81. https:\/\/doi.org\/10.3390\/molecules29010081","journal-title":"Molecules"},{"key":"11268_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","volume":"74","author":"FD Debelle","year":"2008","unstructured":"Debelle FD, Vanherweghem JL, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74:158\u2013169","journal-title":"Kidney Int"},{"key":"11268_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/bioengineering10020173","volume":"10","author":"F Alharbi","year":"2023","unstructured":"Alharbi F, Vakanski A (2023) Machine learning methods for cancer classification using gene expression data: a review. Bioengineering 10:173. https:\/\/doi.org\/10.3390\/bioengineering10020173","journal-title":"Bioengineering"},{"key":"11268_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20140712","volume":"462","author":"JJ Babon","year":"2014","unstructured":"Babon JJ, Lucet IS, Murphy JM et al (2014) The molecular regulation of janus kinase (JAK) activation. Biochem J 462:1\u201313. https:\/\/doi.org\/10.1042\/BJ20140712","journal-title":"Biochem J"},{"key":"11268_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8:204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Ther"},{"key":"11268_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"Zak J, Pratumchai I, Marro BS et al (2024) JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science 384:eade8520. https:\/\/doi.org\/10.1126\/science.ade8520","journal-title":"Science"},{"key":"11268_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.857430","volume":"9","author":"S Mathpal","year":"2022","unstructured":"Mathpal S, Sharma P, Joshi T et al (2022) Identification of zinc-binding inhibitors of matrix metalloproteinase-9 to prevent cancer through deep learning and molecular dynamics simulation approach. Front Mol Biosci 9:857430. https:\/\/doi.org\/10.3389\/fmolb.2022.857430","journal-title":"Front Mol Biosci"},{"key":"11268_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semcancer.2020.05.018","volume":"79","author":"C Carlberg","year":"2022","unstructured":"Carlberg C, Mu\u00f1oz A (2022) An update on vitamin D signaling and cancer. Semin Cancer Biol 79:217\u2013230. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.018","journal-title":"Semin Cancer Biol"},{"key":"11268_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195844","volume":"13","author":"Y Chen","year":"2018","unstructured":"Chen Y, Liu X, Zhang F et al (2018) Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5. PLoS ONE 13:e0195844. https:\/\/doi.org\/10.1371\/journal.pone.0195844","journal-title":"PLoS ONE"},{"key":"11268_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","volume":"22","author":"R Ruan","year":"2023","unstructured":"Ruan R, Li L, Li X et al (2023) Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment. Mol Cancer 22:60. https:\/\/doi.org\/10.1186\/s12943-023-01761-7","journal-title":"Mol Cancer"},{"key":"11268_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139\u2013149. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.01.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"11268_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000487","volume":"8","author":"DL Vallejo Ardila","year":"2020","unstructured":"Vallejo Ardila DL, Walsh KA, Fifis T et al (2020) Immunomodulatory effects of renin\u2013angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases. J ImmunoTher Cancer 8:e000487. https:\/\/doi.org\/10.1136\/jitc-2019-000487","journal-title":"J ImmunoTher Cancer"},{"key":"11268_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-023-03080-9","volume":"23","author":"B Hassani","year":"2023","unstructured":"Hassani B, Attar Z, Firouzabadi N (2023) The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell Int 23:254. https:\/\/doi.org\/10.1186\/s12935-023-03080-9","journal-title":"Cancer Cell Int"},{"key":"11268_CR44","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41590-023-01642-7","volume":"24","author":"SE Di Carlo","year":"2023","unstructured":"Di Carlo SE, Raffenne J, Varet H et al (2023) Depletion of slow-cycling PDGFR\u03b1+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis. Nat Immunol 24:1867\u20131878. https:\/\/doi.org\/10.1038\/s41590-023-01642-7","journal-title":"Nat Immunol"},{"key":"11268_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173727","volume":"891","author":"R Sankhe","year":"2021","unstructured":"Sankhe R, Pai SRK, Kishore A (2021) Tumour suppression through modulation of neprilysin signaling: a comprehensive review. Eur J Pharmacol 891:173727. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173727","journal-title":"Eur J Pharmacol"},{"key":"11268_CR46","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jhep.2023.08.024","volume":"79","author":"Y Meng","year":"2023","unstructured":"Meng Y, Ye F, Nie P et al (2023) Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells. J Hepatol 79:1435\u20131449. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.024","journal-title":"J Hepatol"},{"key":"11268_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12885-020-06733-4","volume":"20","author":"J-Y Yoon","year":"2020","unstructured":"Yoon J-Y, Gedye C, Paterson J, Ailles L (2020) Stem\/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored. BMC Cancer 20:272. https:\/\/doi.org\/10.1186\/s12885-020-06733-4","journal-title":"BMC Cancer"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11268-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11268-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11268-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:56:37Z","timestamp":1771775797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11268-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11268"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11268-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animals or humans were involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}